[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69521672D1 - Topisch verabreichbare zinkphthalocyaninhaltige Mittel - Google Patents

Topisch verabreichbare zinkphthalocyaninhaltige Mittel

Info

Publication number
DE69521672D1
DE69521672D1 DE69521672T DE69521672T DE69521672D1 DE 69521672 D1 DE69521672 D1 DE 69521672D1 DE 69521672 T DE69521672 T DE 69521672T DE 69521672 T DE69521672 T DE 69521672T DE 69521672 D1 DE69521672 D1 DE 69521672D1
Authority
DE
Germany
Prior art keywords
zinc phthalocyanine
topically administrable
containing zinc
agents containing
administrable agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69521672T
Other languages
English (en)
Inventor
William G Love
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Application granted granted Critical
Publication of DE69521672D1 publication Critical patent/DE69521672D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69521672T 1995-01-05 1995-12-14 Topisch verabreichbare zinkphthalocyaninhaltige Mittel Expired - Lifetime DE69521672D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9500116.0A GB9500116D0 (en) 1995-01-05 1995-01-05 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE69521672D1 true DE69521672D1 (de) 2001-08-16

Family

ID=10767610

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521672T Expired - Lifetime DE69521672D1 (de) 1995-01-05 1995-12-14 Topisch verabreichbare zinkphthalocyaninhaltige Mittel

Country Status (12)

Country Link
US (1) US5723148A (de)
EP (1) EP0720853B1 (de)
JP (1) JPH08231428A (de)
KR (1) KR960028918A (de)
AT (1) ATE202934T1 (de)
AU (1) AU4068395A (de)
CA (1) CA2166527A1 (de)
DE (1) DE69521672D1 (de)
GB (1) GB9500116D0 (de)
IL (1) IL116599A0 (de)
NZ (1) NZ280743A (de)
ZA (1) ZA9641B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
EP0911023A1 (de) * 1998-03-20 1999-04-28 Mario Luca Russo Photosensibilisierende Stoffe enthaltende pharmazeutische oder kosmetische Zubereitung
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) * 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
ATE289801T1 (de) * 1998-12-22 2005-03-15 Us Health Verabreichungssystem für wasserunlösliche arzneistoffe
US6608050B2 (en) 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7238367B2 (en) * 2001-10-03 2007-07-03 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
BRPI0415977A (pt) * 2003-10-29 2007-01-23 Johnson & Johnson Consumer Fr composições compreendendo produtos de soja e ácidos dióicos
US8211883B2 (en) 2004-04-01 2012-07-03 Case Western Reserve University Topical delivery of phthalocyanines
EP1909758A1 (de) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Verfahren zur herstelung von liposomalen formulierungen
US20080008818A1 (en) * 2006-06-23 2008-01-10 Miri Seiberg Partially denatured whole soybean extracts and methods of use thereof
US20080089960A1 (en) * 2006-10-16 2008-04-17 Miri Seiberg Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage
CZ298978B6 (cs) * 2006-11-28 2008-03-26 Fyziologický ústav AV CR Liposomální gelový ftalocyaninový prípravek pro fotodynamickou terapii nádorových onemocnení a zpusob jeho prípravy
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US8440641B2 (en) 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
MX366292B (es) * 2013-07-03 2019-07-04 Klox Tech Inc Composiciones biofotónicas que comprenden un cromóforo y un agente gelificante para el tratamiento de heridas.
CA2944201A1 (en) 2014-04-01 2015-10-08 Klox Technologies Inc. Tissue filler compositions and methods of use
CN105363031B (zh) * 2014-09-01 2019-04-02 北京贵千金医药科技有限公司 α-(8-喹啉氧基)单取代酞菁锌治疗银屑病的用途
AU2015337786B2 (en) 2014-10-31 2020-03-26 Klox Technologies Inc. Photoactivatable fibers and fabric media
US10723694B2 (en) * 2018-10-02 2020-07-28 Kuwait University Propargyl-functionalized macrocyclic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5270053A (en) 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
EP0633024A1 (de) * 1993-07-09 1995-01-11 Ciba-Geigy Ag Topisch verabreichbare Zink Phthalocyanin haltige Mittel
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers

Also Published As

Publication number Publication date
GB9500116D0 (en) 1995-03-01
ZA9641B (en) 1996-08-16
IL116599A0 (en) 1996-03-31
US5723148A (en) 1998-03-03
JPH08231428A (ja) 1996-09-10
NZ280743A (en) 1997-03-24
KR960028918A (ko) 1996-08-17
EP0720853B1 (de) 2001-07-11
ATE202934T1 (de) 2001-07-15
EP0720853A1 (de) 1996-07-10
AU4068395A (en) 1996-07-11
CA2166527A1 (en) 1996-07-06

Similar Documents

Publication Publication Date Title
DE69521672D1 (de) Topisch verabreichbare zinkphthalocyaninhaltige Mittel
ZA91353B (en) Pharmaceutical and cosmetic compositions
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
MX9602955A (es) Procedimiento para solubizar activos farmaceuticos dificilmente solubles.
DE69306212D1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
ES2158327T3 (es) Derivados de benzo(g)quinolina.
DE69328681D1 (de) Selbstschmierende polybenzimidazole enthaltende zusammensetzung
PT84690B (pt) Processo de preparacao de novos derivados da benzodiazepina e de composicoes farmaceuticas que os contem
PT99503A (pt) Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE160931T1 (de) Lichtstabile farbzusammensetzungen
DK99987A (da) Oestrogenpraeparater
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
DK0579939T3 (da) Phospholipidderivater
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
NO985079L (no) Eksplosiv formulering
DE59404879D1 (de) Farbbildnergemisch
FR2722094B1 (fr) Composition orale pour reactiver le bronzage de lapeau a base d'un carotenoide et d'un tocopherol
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.
SE8304111L (sv) Aminoderivat av bensyliden-pyrrolo(2,1-b)kinazoliner och bensyliden-pyrido(2,1-b)kinazoliner
NO994787L (no) Forbedringer i eller vedrörende langtidsvirkende antimikrobielle midler
ECSP951482A (es) Heteroaril--oxazolidinonas de 6 eslabones

Legal Events

Date Code Title Description
8332 No legal effect for de